Direktorat Registrasi ObatValid

VINORELBINE TARTRATE

Claim this product
BPOM Number
GKL2543902543A1
Approved
9 October 2025
Expiry
8 October 2030
Form
INJEKSI

About This Registration

VINORELBINE TARTRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2543902543A1. Its current registration status is Valid, with the licence valid until 8 October 2030. The product is registered to CKD OTTO PHARMACEUTICALS - INDONESIA. BPOM first approved this registration in October 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
newaero
Packaging
DUS, 1 VIAL @ 5 ML
Department
Direktorat Registrasi Obat
Data Last Updated
13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

VINORELBINE TARTRATE

Market Intelligence

Owner Portfolio
CKD OTTO PHARMACEUTICALS - INDONESIA holds 48 BPOM registrations
Manufacturer Scale
CKD OTTO PHARMACEUTICALS - INDONESIA produces 48 registered products
Registration Age
Registered for 9 months

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from CKD OTTO PHARMACEUTICALS - INDONESIA

BEVABELL

-DKI2570200149A1
Valid
Approved: May 9, 2026LARUTAN KONSENTRAT UNTUK INFUS
View product →

BORTEZOMIB

-GKL2543902044B1
Valid
Approved: Dec 28, 2025SERBUK INJEKSI LIOFILISASI
View product →

TEZOBELL

-DKL2543901944B1
Valid
Approved: Dec 28, 2025SERBUK INJEKSI LIOFILISASI
View product →

MYREPT

-DKI2584401309A1
Valid
Approved: Aug 31, 2025KAPLET SALUT SELAPUT
View product →

IRINOBELL

-DKL2543902749A1
Valid
Approved: Oct 15, 2025LARUTAN KONSENTRAT UNTUK INFUS
View product →

Products in the same class

PIRACETAM

-GKL0933521349A1
Valid
Approved: May 20, 2026INFUS
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
View product →

SALBRON

-DKL7804407610B1
Valid
Approved: May 2, 2026TABLET
DANKOS FARMA - INDONESIA
View product →

SANKORBIN

-DKL0822245543A1
Valid
Approved: Apr 24, 2026INJEKSI
SANBE FARMA
View product →

LIDIUM

-DKL2017114117A1
Valid
Approved: Mar 18, 2026TABLET SALUT SELAPUT
HOLI PHARMA - INDONESIA
View product →

AMBROXOL HYDROCHLORIDE

-GKL1015710410A1
Valid
Approved: Mar 16, 2026TABLET
ETERCON PHARMA - INDONESIA
View product →
1